Our previous studies demonstrated that the NuRD(MTA1)/CRL4B complex and the SIRT1/CRL4B complex promote stemness and EMT in breast cancer and pancreatic cancer, respectively [24, 25]. This evidence concerns the gene MTA1 and breast carcinoma.